PA-BOOMI
22.2.2024 17:18:30 CET | Business Wire | Press release
BoomiTM, the intelligent integration and automation leader, today announced that Gartner has positioned Boomi as a Leader and placed the company highest for Ability to Execute in its Magic Quadrant for Integration Platform as a Service (iPaaS). This will be the tenth consecutive time Boomi has been named a Leader in the Gartner Magic Quadrant for iPaaS. Gartner evaluated 17 iPaaS providers on their Ability to Execute and Completeness of Vision.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240221163767/en/
Boomi Celebrates Being Positioned Highest for Ability to Execute in the Gartner® Magic Quadrant™ for Integration Platform as a Service (Graphic: Business Wire)
“We believe that being positioned highest for Ability to Execute and recognized as a 10x Leader in the Gartner Magic Quadrant for iPaaS underscores our unrelenting product excellence, innovation, and execution as a team,” said Steve Lucas, CEO at Boomi. “We are pushing the envelope further than ever before to bring groundbreaking innovations to market for the benefit of our customers and partners worldwide, and it is gratifying to see the industry take note of our considerable achievements.”
Trusted by more than 20,000 customers across all industries globally for its speed, ease-of-use, and lower total cost of ownership, the cloud-native, unified, low code, scalable, open, secure, and intelligent Boomi platform helps organizations quickly and easily accelerate business outcomes.
Boomi recently announced significant updates to its platform and business, including:
Product Innovation
- Event Streams – Available through Boomi and in AWS Marketplace, the multi-tenant enterprise message queuing and streaming service allows organizations to create integrations that are more resilient, scalable, and real-time than traditional point-to-point integration processes.
- Boomi AI – Leveraging deidentified metadata, patterns, and best practices from 200 million integrations made with the Boomi platform, Boomi AI offers a simplified user experience that harnesses generative AI to connect and integrate applications, data, processes, people, and things across organizations.
- Boomi GPT – The first offering available in the Boomi AI suite, Boomi GPT brings a simple, conversational experience to the Boomi platform. With Boomi GPT, organizations can harness the power of generative AI to integrate and automate faster than ever before, further democratizing innovation and accelerating business outcomes.
- AI Patents – This year Boomi achieved two new technology patents in the field of AI that challenge the existing paradigms inherent when constructing integration processes. These patents provide additional testament to the company’s innovation leadership and dedication of its talented team of engineers, scientists, and innovators.
- New ISO Certifications – Boomi’s ISO 27001 and 27701 certifications demonstrate the company’s continued commitment to information security and privacy compliance. As one of the only iPaaS vendors that is also FedRAMP Authorized, Boomi is consistently evolving to ensure its compliance security and privacy programs continue to meet the stringent regulatory standards set by governments and its more than 20,000 worldwide customers.
- StateRAMP Authorization – Achieving StateRAMP Authorization reflects Boomi’s unwavering commitment to data security and compliance, and to delivering a secure and reliable solution that government agencies can rely on to safeguard their data and operations.
Business Growth
- Global Growth – Boomi continues to expand globally with recently opened offices in Vancouver, Barcelona, Bengaluru, and a new headquarters based in Conshohocken, PA.
- Leadership Expansion – To help usher Boomi into its next stage of growth, the company welcomed several new executive leaders throughout the past year with experience from Adobe, Business Objects, CA Technologies, Citrix, Marketo, Salesforce, and SAP.
As a category-leading, global software as a service (SaaS) company, Boomi touts a growing community of more than 100,000 members, and one of the largest arrays of global systems integrators (GSIs) in the iPaaS space. The company boasts a worldwide network of approximately 800 partners, and works with the largest hyperscaler cloud service providers.
Boomi has won numerous awards for product innovation and being an employer of choice, including being named to the 2024 list of Best Places to Work by Built In and the CRN Cloud 100 list for innovation in cloud-based technology development. In addition, Boomi has received the prestigious 5-star rating in the CRN Partner Program Guide for two consecutive years, was named a Fire Award honoree for innovation by the Philadelphia Business Journal and a Gold Stevie® Award winner in the American Business Awards for Company of the Year in 2023. Boomi has also been recognized by The Software Report as a Top 100 Software Company and for having one of the Top 50 SaaS CEOs.
To learn more, read the Gartner report: “Magic Quadrant for Integration Platform as a Service.”
Additional Resources
- Learn more about what Boomi’s placement in the Gartner Magic Quadrant for iPaaS means
- Follow Boomi on X (Twitter), LinkedIn, Facebook, and YouTube
Gartner Disclaimer:
Gartner, Magic Quadrant for Integration Platform as a Service, Keith Guttridge, Andrew Comes, Shrey Pasricha, Max van den Berk, Andrew Humphreys, February 19, 2024
Boomi was recognized as Dell Boomi in 2014-2019. The report was previously titled as Magic Quadrant for Enterprise Integration Platform as a Service from 2017-2021 and in 2014. The report was titled as Magic Quadrant for Enterprise Integration Platform as a Service, Worldwide in 2015 & 2016 and as Magic Quadrant for Integration Platform as a Service, Worldwide in 2023.
Gartner does not endorse any vendor, product or service depicted in its research publications and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner’s research organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose. GARTNER is a registered trademark and service mark of Gartner and Magic Quadrant is a registered trademark of Gartner, Inc. and/or its affiliates in the U.S. and internationally and are used herein with permission. All rights reserved. Note: Boomi was recognized as Dell Boomi from 2014 to 2019.
About Boomi
Boomi powers the future of business with intelligent integration and automation. As a category-leading, global software as a service (SaaS) company, Boomi celebrates more than 20,000 global customers and a worldwide network of 800 partners. Organizations turn to Boomi’s award-winning platform to connect their applications, data, and people to accelerate digital transformation. For more information, visit boomi.com.
© 2024 Boomi, LP. Boomi, the ‘B’ logo, and Boomiverse are trademarks of Boomi, LP or its subsidiaries or affiliates. All rights reserved. Other names or marks may be the trademarks of their respective owners.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240221163767/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Owkin to License K Pro AI Scientist and Multimodal Oncology and Immunology Datato Boehringer Ingelheim2.9.2026 14:00:00 CEST | Press release
Owkin, the agentic AI company striving to transform drug discovery and development for biopharma, today announced a license agreement with Boehringer Ingelheim for K Pro, Owkin’s AI Scientist, together with multimodal patient data, aiming to speed up the discovery process across multiple indications in oncology and immunology. This agreement builds upon an initial pilot undertaken by Owkin with Boehringer in 2025. In that pilot Owkin delivered deep spatial insights into the tumor microenvironment of a gene target through its MOSAIC dataset. Under the new agreement, Owkin will license multimodal oncology data to Boehringer and will generate new multimodal data in immunology. Owkin licenses, sources and generates multimodal patient data in collaboration with its global patient data network. Boehringer Ingelheim’s teams will access and analyze this data through K Pro, which provides a single environment to interrogate data and run reproducible analyses. K Pro’s reasoning capabilities supp
Biocytogen Enters into Non-Exclusive Licensing Agreement with Qilu Pharmaceutical for a Fully Human VHH Antibody to Support Innovative Drug Development in Neuroscience2.9.2026 14:00:00 CEST | Press release
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (“Biocytogen”, SSE: 688796; HKEX: 02315) today announced that it has entered into a non-exclusive licensing agreement with Qilu Pharmaceutical Co., Ltd. (“Qilu Pharmaceutical”) for a fully human VHH antibody molecule. Under the agreement, Biocytogen will grant Qilu Pharmaceutical non-exclusive rights to a fully human VHH antibody molecule to support its research and development of innovative therapeutics in the neuroscience field. The licensed VHH antibody molecule was generated from Biocytogen’s proprietary RenNano® platform. The RenNano® platform is designed to discover fully human VHH antibody molecules with favorable specificity, binding affinity, and developability, and can generate molecular building blocks for the design and development of VHH antibodies, bispecific/multispecific antibodies, antibody-drug conjugates, and other innovative modalities. Through this license, Qilu Pharmaceutical may advance the research and development o
Croma-Pharma Introduces Electronic Instructions for Use Across the saypha® Portfolio2.9.2026 13:37:00 CEST | Press release
Healthcare professionals in eligible markets can now access the Instructions for Use for the saypha® portfolio digitally by scanning a QR code on the product packaging Croma-Pharma has introduced electronic Instructions for Use (eIFU) across its saypha® portfolio in markets where applicable regulations permit electronic Instructions for Use to replace printed versions. The transition expands digital access to essential product information for healthcare professionals while reducing the use of printed documentation. Healthcare professionals can access the current approved Instructions for Use by scanning the QR code on the saypha® folding box. The eIFU platform provides direct digital access to the latest approved Instructions for Use. "Innovation extends beyond product development. It also includes how we provide healthcare professionals with access to essential product information," said Andreas Prinz, Chief Executive Officer of Croma-Pharma. "The introduction of electronic Instructio
Moving Forward in Oman: Orascom, Samih Sawiris and Muriya Keep Building2.9.2026 13:13:00 CEST | Press release
Orascom and Muriya press ahead across Hawana Salalah, Jebel Sifah and the US$90M+ As Sodah Island, signalling long-term conviction in Oman’s future, in step with Vision 2040. Across Oman, Orascom Development and its Sultanate platform, Muriya, are moving forward. While parts of the region grow cautious, Muriya has paused nothing, building and delivering across all three destinations: Hawana Salalah, Jebel Sifah and As Sodah Island. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260902781576/en/ Moving Forward in Oman: Orascom, Samih Sawiris and Muriya Keep Building (Photo: AETOSWire) The same steadiness runs through everything Samih Sawiris and Orascom have built, from El Gouna to Andermatt to Mamula Island: identifying extraordinary places and developing them for the long term. “Oman has everything we look for as a long-term developer: stability, natural beauty, and a clear direction for its future. Our continued investment
Aukera Closes €460 Million Structured Credit Facility Led by EIG to Support European Energy Infrastructure Portfolio2.9.2026 13:00:00 CEST | Press release
Aukera, the pan-European battery storage and renewable energy platform backed by AtlasInvest, Reggeborgh and SFPIM (Belgium's sovereign wealth fund), announced the closing of its €460 million structured credit facility, for which EIG, a leading institutional investor in the global energy and infrastructure sectors, served as the lead investor. With the financing in place, Aukera moves into its next phase of growth, combining capital, expertise and delivery capability to build a significant European energy infrastructure platform that develops, finances, constructs and operates assets at scale. The original facility included an initial €200 million commitment and an accordion feature of up to €250 million. The amended facility converts that accordion into a firmly committed €260 million Series 2 tranche, increasing total committed capital to €460 million. The additional capital will support the continued advancement of Aukera's portfolio of renewable energy generation, battery storage a
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
